NCT05873595View on ClinicalTrials.gov

Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease

TerminatedOBSERVATIONAL
Enrollment

29

Participants

Timeline

Start Date

June 20, 2023

Primary Completion Date

February 26, 2024

Study Completion Date

February 26, 2024

Conditions
Peyronie's Disease
Trial Locations (7)

33136

Endo Pharmaceuticals Clinical Site 3, Miami

43230

Endo Pharmaceuticals Clinical Site 7, Gahanna

46143

Endo Pharmaceuticals Clinical Site 6, Greenwood

48912

Endo Pharmaceuticals Clinical Site 5, Lansing

77030

Endo Pharmaceuticals Clinical Site 4, Houston

84057

Endo Pharmaceuticals Clinical Site 1, Orem

92120

Endo Pharmaceuticals Clinical Site 2, San Diego

Sponsors
All Listed Sponsors
lead

Endo Pharmaceuticals

INDUSTRY